Correlation Between AN2 Therapeutics and Oric Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Oric Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Oric Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Oric Pharmaceuticals, you can compare the effects of market volatilities on AN2 Therapeutics and Oric Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Oric Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Oric Pharmaceuticals.

Diversification Opportunities for AN2 Therapeutics and Oric Pharmaceuticals

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between AN2 and Oric is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Oric Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oric Pharmaceuticals and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Oric Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oric Pharmaceuticals has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Oric Pharmaceuticals go up and down completely randomly.

Pair Corralation between AN2 Therapeutics and Oric Pharmaceuticals

Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 1.29 times more return on investment than Oric Pharmaceuticals. However, AN2 Therapeutics is 1.29 times more volatile than Oric Pharmaceuticals. It trades about 0.21 of its potential returns per unit of risk. Oric Pharmaceuticals is currently generating about 0.15 per unit of risk. If you would invest  107.00  in AN2 Therapeutics on August 25, 2024 and sell it today you would earn a total of  27.00  from holding AN2 Therapeutics or generate 25.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

AN2 Therapeutics  vs.  Oric Pharmaceuticals

 Performance 
       Timeline  
AN2 Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in AN2 Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, AN2 Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Oric Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oric Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, Oric Pharmaceuticals is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

AN2 Therapeutics and Oric Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AN2 Therapeutics and Oric Pharmaceuticals

The main advantage of trading using opposite AN2 Therapeutics and Oric Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Oric Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oric Pharmaceuticals will offset losses from the drop in Oric Pharmaceuticals' long position.
The idea behind AN2 Therapeutics and Oric Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account